Home › Funds › BOONE CAPITAL MANAGEMENT LLC › IONS

BOONE CAPITAL MANAGEMENT LLC position in IONS

IONIS PHARMACEUTICALS INC · Health Care

BOONE CAPITAL MANAGEMENT LLC reported holding 519,977 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$41.2M, representing 9.64% of its reported portfolio and ranking #4 among its reported holdings. BOONE CAPITAL MANAGEMENT LLC has disclosed IONS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)519.98K sh
Reported value held$41.23M
Portfolio Weight9.64%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BOONE CAPITAL MANAGEMENT LLC's IONS position evolved

BOONE CAPITAL MANAGEMENT LLC first disclosed a stake in IONS in Q3 2025 at 417,833 shares (US$27.3M). The position peaked in Q2 2026 at 519,977 shares, worth US$41.2M. Across 4 filings, BOONE CAPITAL MANAGEMENT LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 519,977 shares valued at US$41.2M — an increase of 19,455 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 417.83K $27.33M New
Q4 2025 417.83K $33.05M Hold
Q1 2026 500.52K $37.58M Add
Q2 2026 519.98K $41.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has BOONE CAPITAL MANAGEMENT LLC held IONS?

BOONE CAPITAL MANAGEMENT LLC has disclosed IONS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is BOONE CAPITAL MANAGEMENT LLC's current position in IONS?

As of Q2 2026, BOONE CAPITAL MANAGEMENT LLC holds 519.98K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $41.23M, representing 9.64% of its reported portfolio and ranking #4.

Has BOONE CAPITAL MANAGEMENT LLC been buying or selling IONS?

In the latest 13F filing (Q2 2026), BOONE CAPITAL MANAGEMENT LLC increased its position in IONS. The position peaked in Q2 2026 at 519.98K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.